My investment thesis is that Cancer will be cured in this decade and the Magnificent Seven will move us toward the goal CTIX NWBO PCYC THLD SNTA IMUC SBFM ______________________________________________________________ The next Wave will be Regenerative Medicine and a group of biotechs I call the Cell Biology Seven will lead that wave. ISCO is now the leader of that group and may become the dominant supplier to others in the field in the same manner that MSFT came to dominate computer operating systems in prior decades. The other six are BTX MEDS NNVC BCLI ARWR SRPT